MindMaze Therapeutics Holding SA (MMTX) CHF4.00

Sell:0.41 CHFBuy:0.42 CHFPrice decreased0.02 CHF (4.98%)

Prices delayed by at least 15 minutes
Sell:0.41 CHF
Buy:0.42 CHF
Change:Price decreased0.02 CHF (4.98%)
Prices delayed by at least 15 minutes
Sell:0.41 CHF
Buy:0.42 CHF
Change:Price decreased0.02 CHF (4.98%)
Prices delayed by at least 15 minutes

Company Information

About this company

MindMaze Therapeutics Holding SA, formerly known as RELIEF THERAPEUTICS Holding SA, is a Switzerland-based company that engages in research, development, production, and sale of biotechnology, pharmaceutical, diagnostic, therapeutic, chemical, and cosmetic products. The Company acquires and manages patents, licenses, and intellectual property, provides preclinical, clinical, and regulatory services, and may establish subsidiaries worldwide. The Company also participates in the acquisition, holding, and financing of interests in companies, offers management services to affiliates, and develops scientific and economic solutions for disease treatment and therapeutic approaches. Additionally, the Company may acquire, hold, and sell trademarks and other IP rights globally, and provide or obtain financing through loans or guarantees to support its corporate purpose.

Key people

Walid N. Hanna
Non-Executive Chairman of the Board
Zach Henderson
Chief Executive Officer
Jeremy Meinen
Chief Financial Officer, Treasurer
Alexandre Capet
Chief Operating and Strategy Officer
Giorgio Reiner
Chief Scientific Officer
Paolo Galfetti
Chief Business Officer
Olaf Blanke
Non-Executive Director
Martin Reiss
Non-Executive Director
Click to see more

Key facts

  • Shares in issue
    159.10m
  • EPIC
    MMTX
  • ISIN
    CH1251125998
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    CHF 70.24m
  • Employees
    31
  • Exchange
    SIX Swiss Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.